Lepu Biopharma Co., Ltd. is an innovation-driven biopharmaceutical company, which focuses on oncology therapeutics and endeavor to continuously develop a market differentiating pipeline by combining in-house research and development and strategic collaborations, strengthen in-house manufacturing and commercialize its pipeline products in China through dedicated sales and marketing forces and internationally via partnerships. The company was founded by Zhong Jie Pu on January 19, 2018 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company